SCHEMBL16601907

SCHEMBL16601907

O=C(/C=C/c1ccc(OCO)c(OCO)c1)OCCCc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B10 O60218 6/20 0.65
AKR1B1 P15121 6/20 0.65
ALOX5 P09917 3/20 0.64
TTR P02766 4/20 0.63
CYP3A4 P08684 2/20 0.57
ALOX15 P16050 2/20 0.57
ALOX12 P18054 2/20 0.57
MAPK1 P28482 2/20 0.57
HSD17B10 Q99714 2/20 0.57
KDM4E B2RXH2 1/20 0.57
MEN1 O00255 1/20 0.57
GMNN O75496 1/20 0.57
ALDH1A1 P00352 1/20 0.57
EGFR P00533 1/20 0.57
LMNA P02545 1/20 0.57
ESR1 P03372 1/20 0.57
ERBB2 P04626 1/20 0.57
APP P05067 1/20 0.57
LCK P06239 1/20 0.57
FYN P06241 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18534005 0.93 TTR (0.74) AKR1B10AKR1B1ALOX5TTRKDM4E
SCHEMBL16601908 0.93 TTR (0.72) AKR1B10AKR1B1ALOX5TTRCYP3A4
SCHEMBL2602740 0.89 AKR1B10 (0.63) AKR1B10AKR1B1ALOX5TTRCYP3A4
SCHEMBL16601909 0.85 CA12 (0.65) AKR1B10AKR1B1TTRKDM4EALDH1A1
SCHEMBL15384083 0.85 TTR (0.86) AKR1B10AKR1B1ALOX5TTRKDM4E
SCHEMBL15384911 0.83 ALOX5 (0.66) AKR1B10AKR1B1ALOX5TTRCYP3A4
SCHEMBL2602742 0.81 TTR (0.69) AKR1B10AKR1B1ALOX5TTRCYP3A4
SCHEMBL2605864 0.81 ALOX5 (0.63) AKR1B10AKR1B1ALOX5TTRCYP3A4
SCHEMBL15384915 0.81 ALOX5 (0.63) AKR1B10AKR1B1ALOX5TTRCYP3A4
SCHEMBL3249348 0.81 AKR1B10 (0.84) AKR1B10AKR1B1ALOX5TTRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9040579-B2 Combination therapy using coenzyme Q10 and a caffeic acid-derived ester Chemigen (US) 2015-05-26 US disclosed
US-8993621-B2 Caffeic acid derivatives and their use in improving neuronal cell viability CHEMIGEN, INC. (US) 2015-03-31 US disclosed